Targeted Fucosylation of Glycans with Engineered Bacterial Fucosyltransferase Variants
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1002/cctc.202200037
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2022
- Urheber
- DOI
-
10.18154/RWTH-2022-07716
- URN
-
urn:nbn:de:101:1-2022082501352522220364
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:41 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Heine, Viktoria
- Pelantová, Helena
- Bojarová, Pavla
- Křen, Vladimír
- Elling, Lothar
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2022
Ähnliche Objekte (12)
"CAR-engineered lymphocytes for targeted therapy of leukemia and lymphoma"
Engineered bacterial host for genetic encoding of physiologically stable protein nitration
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Genome-wide association and targeted analysis of copy number variants with psoriatic arthritis in German patients
Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells
Superoxide Biosensing with Engineered Cytochrome c
Influence of NOD2 risk variants on hepatic encephalopathy and association with inflammation, bacterial translocation and immune activation
Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells
Towards recombinantly produced milk proteins: Physicochemical and emulsifying properties of engineered whey protein beta-lactoglobulin variants
Towards recombinantly produced milk proteins: Physicochemical and emulsifying properties of engineered whey protein beta-lactoglobulin variants
Targeted parallel DNA sequencing detects circulating tumor-associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma
"CAR-engineered lymphocytes for targeted therapy of leukemia and lymphoma"
Engineered bacterial host for genetic encoding of physiologically stable protein nitration
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Genome-wide association and targeted analysis of copy number variants with psoriatic arthritis in German patients
Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells
Superoxide Biosensing with Engineered Cytochrome c
Influence of NOD2 risk variants on hepatic encephalopathy and association with inflammation, bacterial translocation and immune activation
Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells
Towards recombinantly produced milk proteins: Physicochemical and emulsifying properties of engineered whey protein beta-lactoglobulin variants
Towards recombinantly produced milk proteins: Physicochemical and emulsifying properties of engineered whey protein beta-lactoglobulin variants
Targeted parallel DNA sequencing detects circulating tumor-associated variants of the mitochondrial and nuclear genomes in patients with neuroblastoma
"CAR-engineered lymphocytes for targeted therapy of leukemia and lymphoma"
Engineered bacterial host for genetic encoding of physiologically stable protein nitration
Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy
Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies
Genome-wide association and targeted analysis of copy number variants with psoriatic arthritis in German patients
Targeted delivery of an ADP-ribosylating bacterial toxin into cancer cells
Superoxide Biosensing with Engineered Cytochrome c
Influence of NOD2 risk variants on hepatic encephalopathy and association with inflammation, bacterial translocation and immune activation
Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells
Towards recombinantly produced milk proteins: Physicochemical and emulsifying properties of engineered whey protein beta-lactoglobulin variants
Towards recombinantly produced milk proteins: Physicochemical and emulsifying properties of engineered whey protein beta-lactoglobulin variants